- Home
- HCP vs ASND Comparison
HCP vs ASND Comparison
Compare HCP & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCP
- ASND
- Stock Information
- Founded
- HCP 2012
- ASND 2006
- Country
- HCP United States
- ASND Denmark
- Employees
- HCP N/A
- ASND N/A
- Industry
- HCP EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- HCP Technology
- ASND Health Care
- Exchange
- HCP Nasdaq
- ASND Nasdaq
- Market Cap
- HCP 6.9B
- ASND 7.7B
- IPO Year
- HCP 2021
- ASND 2015
- Fundamental
- Price
- HCP $33.91
- ASND $138.21
- Analyst Decision
- HCP Hold
- ASND Strong Buy
- Analyst Count
- HCP 14
- ASND 13
- Target Price
- HCP $32.80
- ASND $191.77
- AVG Volume (30 Days)
- HCP 1.9M
- ASND 427.4K
- Earning Date
- HCP 12-05-2024
- ASND 02-05-2025
- Dividend Yield
- HCP N/A
- ASND N/A
- EPS Growth
- HCP N/A
- ASND N/A
- EPS
- HCP N/A
- ASND N/A
- Revenue
- HCP $654,890,000.00
- ASND $365,187,374.00
- Revenue This Year
- HCP $15.03
- ASND $7.33
- Revenue Next Year
- HCP $14.88
- ASND $83.72
- P/E Ratio
- HCP N/A
- ASND N/A
- Revenue Growth
- HCP 16.29
- ASND 115.54
- 52 Week Low
- HCP $20.89
- ASND $111.09
- 52 Week High
- HCP $34.21
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- HCP 56.83
- ASND 62.94
- Support Level
- HCP $33.72
- ASND $128.45
- Resistance Level
- HCP $33.95
- ASND $141.48
- Average True Range (ATR)
- HCP 0.17
- ASND 4.52
- MACD
- HCP 0.03
- ASND 0.86
- Stochastic Oscillator
- HCP 90.74
- ASND 91.32
About HCP HashiCorp Inc.
HashiCorp Inc is engaged in solving the infrastructure challenges of cloud adoption by enabling an operating model that unlocks the full potential of modern public and private clouds. Its cloud operating model provides consistent workflows and a standardized approach to automate the processes involved in delivering applications in the cloud: infrastructure provisioning, security, networking, and application deployment. Its main commercial products are Terraform, Vault, Consul, and Nomad.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.